Clinical Trial Update: Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study evaluating AL3818 in combination with nivolumab for solid tumors; the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• AL3818
• nivolumab (nivolumab)

Snippet

Sponsor: Sarcoma Oncology Research Center, LLC | Conditions: Solid Tumor, Adult, Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING